The FY2026 Research Budget: How Congress Saved $5 Billion in University Overhead — and What Researchers Still Face

When the House passed its FY2026 spending package with $48.7 billion for NIH — rejecting the administration's proposed 40% cut — the headlines focused on what was saved. But the real story runs deeper than any single agency's budget line. Across six major science agencies, Congress assembled a budget that preserves the architecture of American research funding while quietly signaling where the political winds are shifting.

And beneath the topline numbers, a separate fight over indirect cost rates nearly stripped $5.24 billion annually from university research infrastructure — a threat that courts and Congress have now blocked, but that could resurface in new forms.

The Full Landscape: Six Agencies, One Story

The FY2026 science budget is best understood not as a collection of individual agency decisions but as a single statement about national research priorities. Here is what Congress actually funded.

NIH: $48.7 billion. An increase of $415 million over FY2025 — essentially flat after inflation, but a universe away from the administration's proposed cut to roughly $29 billion. Congress maintained Pell Grant maximums at $7,395, preserved TRIO and GEAR UP programs that the administration wanted to eliminate, and funded the Institute of Education Sciences at $790 million, triple the administration's request.

NSF: $8.75 billion. This supports roughly 10,000 new awards and more than 250,000 scientists, technicians, teachers, and students. The number matters less than what it preserves: NSF's proposal-driven, investigator-initiated research model, which the administration had signaled it wanted to restructure around narrower priority areas.

DOE Office of Science: $8.4 billion. The department's broader non-defense budget came in at $16.78 billion, with $3.1 billion for energy efficiency and renewable energy programs. Notably, this preserves funding for the Genesis Mission AI initiative and the national laboratory system at a time when the administration had proposed cutting clean energy research significantly.

NASA: $24.44 billion. The Science Mission Directorate received $7.25 billion — avoiding a proposed 47% cut that would have terminated 55 active missions. Human exploration funding increased, reflecting bipartisan consensus around the Artemis program even as robotic science was targeted for cuts.

NOAA: $6.17 billion. The National Weather Service received $1.46 billion for improved forecasting and staffing. Climate and coastal research programs were maintained, and weather satellite continuity was preserved — all areas the administration had proposed shrinking.

EPA: $8.82 billion. State-level clean water and air programs were protected, and the Energy Star efficiency program was retained despite proposals to eliminate it.

The pattern is consistent: Congress broadly rejected the administration's proposed restructuring of federal science, preserving existing program architectures and funding levels with modest increases. But "preserved" is not "expanded," and researchers should understand what flat funding means in practice.

The Indirect Cost War: What Actually Happened

The most consequential fight in research funding this year had nothing to do with topline budgets. On February 7, 2025, NIH issued Notice NOT-OD-25-068, which imposed a flat 15% cap on indirect cost recovery for all new and existing grants to institutions of higher education.

To understand why this was seismic, you need to understand how research universities actually work. Indirect costs — also called facilities and administrative (F&A) costs — cover the infrastructure that makes research possible: laboratory buildings, utilities, IT systems, regulatory compliance offices, hazardous waste disposal, institutional review boards, technology transfer operations. Universities negotiate these rates individually with the federal government, and they typically range from 30% to 60% of direct research costs, with the FY2024 national average at 37.2%.

A 15% cap would not trim overhead. It would demolish the financial model that sustains research infrastructure at every major university in the country.

The numbers are staggering. Peer-reviewed analysis published this year projects that a 15% F&A cap would strip approximately $5.24 billion annually from university research operations. Public universities would lose $2.99 billion; private universities $2.25 billion. The per-capita impact hits hardest in research-intensive states: Connecticut at $48.03 per capita, Maryland at $35.03, the District of Columbia at $32.58, and Massachusetts at $31.69.

At the institutional level, the nation's most research-productive universities would face 15–20% annual funding cuts. California's university system stood to lose $804 million. New York: $632 million. Texas: $310 million.

Courts and Congress Both Intervened

The 15% cap met opposition from two directions simultaneously.

In the courts, U.S. District Judge Angel Kelley permanently barred NIH from implementing the cap, ruling that the agency violated federal statute, acted in an "arbitrary and capricious" manner, and failed to follow required rulemaking procedures. The 1st U.S. Circuit Court of Appeals upheld the ruling unanimously, concluding that NIH violated both statutory law and its own regulatory procedures.

In Congress, the FY2026 appropriations bills include language that blocks the cap across multiple agencies. Sections 542 and 313 of the Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act require the Department of Commerce, NASA, NSF, and DOE to continue using negotiated indirect cost rates from FY2024 and prohibit using FY2026 funds to "develop, modify, or implement changes" to those rates. The defense spending bill separately protects the $9 billion DOD spends annually on university research from indirect cost rate reductions below 2024 levels.

The combined effect is a firewall: for FY2026, negotiated rates are protected by both judicial injunction and legislative prohibition.

Why the Threat Has Not Passed

Researchers would be wrong to treat the indirect cost battle as settled. Three dynamics keep the risk alive.

Executive persistence. The administration has signaled that the 15% cap reflects a policy priority, not a one-time experiment. Future budget proposals may include legislative language to override court rulings, and a new rulemaking process — following proper Administrative Procedure Act requirements — could survive the legal challenges that sank the first attempt.

DOE already moved. Separate from the NIH controversy, DOE implemented a standardized 15% indirect cost rate for all new grants to institutions of higher education. This was done through a different mechanism and has not been subject to the same legal challenges. Researchers at universities receiving DOE grants are already operating under the reduced rate, and the precedent could embolden other agencies to pursue similar policies through proper channels.

Political dynamics. The argument that universities waste federal research dollars on administrative overhead has bipartisan appeal. Even members of Congress who voted to block the cap have expressed interest in "modernizing" indirect cost rate negotiations. The next iteration may come not as an executive action but as legislation, which courts would evaluate under a very different standard.

What Flat Funding Actually Means

Even with the indirect cost cap blocked, researchers face a more subtle challenge: flat nominal funding in an inflationary environment.

NIH's $415 million increase sounds meaningful until you account for biomedical research inflation, which the Biomedical Research and Development Price Index pegs at roughly 3–4% annually. Against a $48.7 billion base, that translates to roughly $1.5–2 billion in real purchasing power erosion. NIH can fund the same number of grants, but each grant buys less laboratory time, fewer research personnel, and less equipment.

The same math applies across agencies. NSF's $8.75 billion, DOE's $8.4 billion, and NASA's $7.25 billion for science all represent maintenance of current capacity, not expansion. No agency received the kind of real-dollar increase that would fund new program lines or significantly increase award rates.

For individual researchers, this means the competitive landscape is not improving. NIH study section paylines remain in the low-to-mid teens percentile. NSF proposal success rates hover around 25%. The number of faculty competing for these awards continues to grow while the pool of funded awards stays essentially constant.

Strategic Implications for Grant Seekers

This budget environment creates specific strategic pressures that grant seekers should plan around.

Diversify across agencies. With no single agency offering significantly expanded funding, researchers benefit from submitting to multiple agencies where their work qualifies. A biomedical researcher with a computational component might target both NIH and DOE. An environmental scientist could pursue both NSF and EPA funding. Cross-agency eligibility is more common than many investigators realize.

Watch for new program lines within flat budgets. Agencies routinely retire programs and launch new ones even when topline funding is flat. NSF's Tech Labs initiative, DOE's Genesis Mission, and NIH's streamlined application process all create fresh funding opportunities within existing budgets. The researchers who capture these opportunities are the ones monitoring program announcements closely, not just waiting for their usual study sections.

Protect your indirect cost infrastructure. If you are a department chair, dean, or research administrator, the indirect cost fight is not over. Build relationships with your government affairs office. Participate in comment periods when agencies propose rate changes. The university-level advocacy that helped block the 15% cap needs to continue.

Plan for real-dollar erosion. If your current grant runs through FY2028, budget conservatively. Personnel costs are rising faster than grant budgets, and equipment and supply costs follow. Build contingency into your proposals and consider phased spending plans that front-load the most expensive work.

Leverage the political environment. Congress clearly values research funding — it rejected dramatic cuts across every science agency. But congressional support is reactive, not proactive: it preserves what exists rather than building what is needed. Frame your proposals around national priorities that have bipartisan support (national security, economic competitiveness, public health preparedness), and you align with the funding environment Congress has signaled it will sustain.

The FY2026 budget is not a victory or a defeat for American research. It is a holding pattern — one that preserves the system's architecture while the political fight over its future continues. Researchers who understand both the protections that are in place and the pressures that remain will navigate it most effectively.

Granted tracks funding opportunities across all federal agencies and can help you identify programs where your research fits as the FY2026 budget translates into specific solicitations.